Abstract
The Mycobacterium genus is comprised of over 30 mdivldual species with a large majority being saphrophytes. However, research on these bacteria has focused primarily on the pathogens Mycobacterium bow, Mycobacterium tuberculosis, and Mycobacterium leprae, and opportunistic pathogens such as the Mycobacterium avium complex and Mycobacterium kansasil. These medically important Mycobacterium spp. have been studied extensively in terms of antigenicity (1,2), pathogenicity (3,4), and physiology (5,6), and with the development of genetic transformation techniques for mycobacteria (7), a new era of dedicated efforts to define these organisms at the genomic level was established Over the past decade, such efforts have been underscored by the isolation of mycobacterial genes encoding immunodommant proteins (2,8–10), virulence factors (11–13) and the biosynthesis of secondary products (14,15); as well as the establishment of genome sequencing projects for M leprae and M. tuberculosis (16,17). Essential to these accomplishments was the development of efficient means to isolate high quality mycobacterial genomic DNA.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.